HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jürgen Sonnemann Selected Research

2- morpholin- 4- yl- 6- thianthren- 1- yl- pyran- 4- one

3/2021Cooperative treatment effectiveness of ATR and HSP90 inhibition in Ewing's sarcoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jürgen Sonnemann Research Topics

Disease

28Neoplasms (Cancer)
01/2023 - 05/2004
9Ewing Sarcoma (Sarcoma, Ewing)
09/2023 - 10/2003
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2022 - 01/2007
4Carcinoma (Carcinomatosis)
02/2006 - 05/2004
3Lung Neoplasms (Lung Cancer)
06/2015 - 06/2004
3Prostatic Neoplasms (Prostate Cancer)
11/2007 - 07/2004
3Medulloblastoma
01/2007 - 03/2006
2Carcinogenesis
01/2023 - 03/2021
2Colorectal Neoplasms (Colorectal Cancer)
07/2022 - 12/2021
2Cystic Fibrosis (Mucoviscidosis)
05/2015 - 01/2015
2Inflammation (Inflammations)
01/2015 - 02/2014
2Necrosis
02/2014 - 12/2008
2Ovarian Neoplasms (Ovarian Cancer)
07/2008 - 07/2006
1Genomic Instability
01/2023
1Mitochondrial Diseases (Mitochondrial Disease)
01/2023
1Neoplasm Metastasis (Metastasis)
09/2022
1Diabetes Complications
01/2021
1Polyploidy
11/2020
1Ovarian Epithelial Carcinoma
10/2017
1Bacterial Infections (Bacterial Infection)
02/2014
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
10/2013
1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
10/2013
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
11/2010
1Hepatoblastoma
08/2008
1Hepatocellular Carcinoma (Hepatoma)
08/2008
1Bone Diseases (Bone Disease)
11/2007
1Breast Neoplasms (Breast Cancer)
03/2007
1Primitive Neuroectodermal Tumors (PNET)
11/2006

Drug/Important Bio-Agent (IBA)

14Histone Deacetylase InhibitorsIBA
01/2023 - 03/2005
9VorinostatFDA Link
06/2015 - 03/2005
7LigandsIBA
04/2012 - 07/2004
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2012 - 07/2004
5Antineoplastic Agents (Antineoplastics)IBA
06/2015 - 02/2006
5Butyric Acid (Butanoic Acid)IBA
07/2008 - 03/2005
3MicroRNAs (MicroRNA)IBA
09/2022 - 01/2021
3Etoposide (VP 16)FDA LinkGeneric
01/2016 - 03/2006
3Vincristine (Oncovin)FDA LinkGeneric
01/2016 - 06/2004
3Protease Inhibitors (Protease Inhibitor)IBA
05/2015 - 02/2014
3Cytostatic AgentsIBA
08/2008 - 06/2004
3Protein Kinase CIBA
01/2007 - 06/2004
3trichostatin A (A 300)IBA
03/2006 - 03/2005
2Caspase 3 (Caspase-3)IBA
09/2023 - 02/2006
2Irinotecan (Camptosar)FDA LinkGeneric
07/2022 - 12/2021
2entinostat (MS 275)IBA
12/2021 - 11/2007
2Sirtuin 1IBA
01/2018 - 01/2016
2Histone Deacetylases (Histone Deacetylase)IBA
01/2017 - 10/2013
2Peptide Hydrolases (Proteases)FDA Link
05/2015 - 01/2015
2Protein Isoforms (Isoforms)IBA
10/2013 - 07/2004
2Caspase 8 (Caspase-8)IBA
04/2012 - 11/2007
2TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
04/2012 - 08/2008
2nutlin 3IBA
02/2012 - 06/2011
2Diphosphonates (Bisphosphonates)IBA
11/2007 - 10/2003
2Paclitaxel (Taxol)FDA LinkGeneric
07/2006 - 06/2004
2Protein Kinases (Protein Kinase)IBA
07/2004 - 06/2004
13,4-dihydroxybenzohydroxamic acidIBA
09/2023
13-aminopyridine-2-carboxaldehyde thiosemicarbazone (triapine)IBA
09/2023
1Ribonucleotide Reductases (Ribonucleotide Reductase)IBA
09/2023
1SirtuinsIBA
01/2023
1CateninsIBA
09/2022
1Immune Checkpoint InhibitorsIBA
09/2022
1B7-H1 AntigenIBA
09/2022
1DNA (Deoxyribonucleic Acid)IBA
07/2022
12- morpholin- 4- yl- 6- thianthren- 1- yl- pyran- 4- oneIBA
03/2021
15- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamideIBA
03/2021
1Membrane Proteins (Integral Membrane Proteins)IBA
03/2021
1Glucose (Dextrose)FDA LinkGeneric
01/2021
12- (3- (4- ((2,6- dimethylmorpholino)methyl)styryl)- 1H- indazol- 6- yl)- 5'- methoxyspiro(cyclopropane- 1,3'- indolin)- 2'- oneIBA
11/2020
1centrinoneIBA
11/2020
1SP2509IBA
11/2018
1Apoptosis Inducing FactorIBA
01/2018
1tenovin-1IBA
01/2018
1Cisplatin (Platino)FDA LinkGeneric
10/2017
1Transcription Factors (Transcription Factor)IBA
01/2017
1SRT1720IBA
01/2016
1ResveratrolIBA
01/2016
1Polylactic Acid-Polyglycolic Acid CopolymerIBA
06/2015
1Anti-Bacterial Agents (Antibiotics)IBA
01/2015
1Leukocyte Elastase (Neutrophil Elastase)IBA
02/2014
1Peroxidase (Myeloperoxidase)IBA
02/2014
1InterleukinsIBA
02/2014
1Small Interfering RNA (siRNA)IBA
10/2013
1Prednisone (Sone)FDA LinkGeneric
10/2013
1Erlotinib Hydrochloride (CP 358,774)FDA Link
04/2011
1Gefitinib (Iressa)FDA Link
04/2011
1Lapatinib (GW572016)FDA Link
04/2011
1Tyrosine Kinase InhibitorsIBA
04/2011
1ErbB Receptors (EGF Receptor)IBA
04/2011
1Insulin (Novolin)FDA Link
11/2010
1Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric
07/2008
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
07/2008
1Zoledronic Acid (Zometa)FDA Link
11/2007
1rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA
03/2007
1rho Guanine Nucleotide Dissociation Inhibitor alphaIBA
03/2007
1Busulfan (Busulfex)FDA Link
03/2007
1Protein Kinase C-epsilonIBA
01/2007
1NPC 15437IBA
01/2007

Therapy/Procedure

10Therapeutics
07/2022 - 10/2003
3Drug Therapy (Chemotherapy)
09/2023 - 12/2008
1Immunotherapy
12/2008
1Radiotherapy
01/2007